Search

Your search keyword '"Arbelo E."' showing total 431 results

Search Constraints

Start Over You searched for: Author "Arbelo E." Remove constraint Author: "Arbelo E."
431 results on '"Arbelo E."'

Search Results

1. Present criteria for prophylactic ICD implantation: Insights from the EU-CERT-ICD (Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in EUrope) project

2. Clinical Management of Brugada Syndrome: Commentary From the Experts

3. Head-to-head comparison of pulsed field ablation, very high power-short duration, cryoballoon and conventional radiofrequency ablation by LGE-MRI-based ablation lesion assessment

4. Cardiac magnetic resonance to evaluate 3D ventricular substrate depth: Prognostic implications for VT ablation approach

5. Advanced practice nurse-coordinated same-day-discharge after atrial fibrillation ablation

6. Cardiac magnetic resonance to predict appropriate therapies in secondary prevention

7. Implantable Loop Recorders in patients with Brugada Syndrome: the BruLoop Study

8. Improving functional substrate delineation for ablation of ventricular tachycardia using high-density electroanatomic mapping and double ventricular extra stimuli protocol

9. Non-invasive mapping of atrial slow-conduction areas and validation by endocardial isochronal mapping to predict atrial fibrillation recurrence after ablation

10. Implant failure predictors of left bundle branch pacing used as cardiac resynchronization therapy: importance of left ventricular diameter and QRS morphology

11. Post-ablation atrial arrhythmogenic channels predict atrial fibrillation recurrence - iatrogenic substrate revisited

13. Brillouin light scattering study of Co$_{2}$Cr$_{0.6}$Fe$_{0.4}$Al and Co$_{2}$FeAl Heusler compounds

15. Non-invasive electrocardiographic imaging for the characterization of complex atrial tachyarrhythmias

16. Stepwise application of ECG and electrogram based criteria to ensure left bundle branch pacing

17. Noninvasive stratification of ventricular substrate by electrocardiographic imaging

18. Local conduction velocities determined by non-invasive electrocardiographic imaging predict arrhythmia-free survival after pulmonary vein isolation

19. Evolution of deceleration zones during VT ablation and relation with cardiac magnetic resonance

21. European Society of Cardiology quality indicators for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

22. Cardiac injury before and after COVID-19. A longitudinal MRI study

24. Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls

25. 2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

26. European Society of Cardiology quality indicators for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death Developed in collaboration with the European Heart Rhythm Association of the European Society of Cardiology

28. Transethnic genome-wide association study provides insights in the genetic architecture and heritability of long QT syndrome

29. 2019 ESC Guidelines for themanagement of patients with supraventricular tachycardia

30. European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis

31. European Society of Cardiology Quality Indicators for Cardiovascular Disease Prevention: developed by the Working Group for Cardiovascular Disease Prevention Quality Indicators in collaboration with the European Association for Preventive Cardiology of the European Society of Cardiology

32. Author Correction: Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility (Nature Genetics, (2022), 54, 3, (232-239), 10.1038/s41588-021-01007-6)

33. Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility

34. Discerning the Ambiguous Role of Missense TTN Variants in Inherited Arrhythmogenic Syndromes

36. Septal flash correction with His-Purkinje pacing predicts echocardiographic response in resynchronization therapy

37. Brugada Syndrome in Women: What Do We Know After 30 Years?

38. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy

39. European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis The Task Force for the management of COVID-19 of the European Society of Cardiology

40. 2019 ESC Guidelines for themanagement of patients with supraventricular tachycardia

41. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

42. Outcomes of novel pacing technologies with right ventricular pacing as a primary strategy for patient undergoing transvenous permanent pacing regardless of pacing indication

43. Sport practice in hypertrophic cardiomyopathy: running to stand still?

44. Pediatric Malignant Arrhythmias Caused by Rare Homozygous Genetic Variants in TRDN: A Comprehensive Interpretation

45. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation, developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC), developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC

46. Adenosine usage during AF ablation in Europe and selected long-term findings from the ESC-EHRA EORP Atrial Fibrillation Ablation Long-Term registry

47. Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls

48. Rare variants associated with arrhythmogenic cardiomyopathy: Reclassification five years later

Catalog

Books, media, physical & digital resources